Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial von Voorhees, Peter M., Kaufman, Jonathan L., Laubach, Jacob, Sborov, Douglas W., Reeves, Brandi, Rodriguez, Cesar, Chari, Ajai, Silbermann, Rebecca, Costa, Luciano J., Anderson, Larry D., Nathwani, Nitya, Shah, Nina, Efebera, Yvonne A., Holstein, Sarah A., Costello, Caitlin, Jakubowiak, Andrzej, Wildes, Tanya M., Orlowski, Robert Z., Shain, Kenneth H., Cowan, Andrew J., Murphy, Sean, Lutska, Yana, Pei, Huiling, Ukropec, Jon, Vermeulen, Jessica, de Boer, Carla, Hoehn, Daniela, Lin, Thomas S., Richardson, Paul G.

Volltext

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study von Yimer, Habte, Melear, Jason, Faber, Edward, Bensinger, William I., Burke, John M., Narang, Mohit, Stevens, Don, Gunawardena, Sriya, Lutska, Yana, Qi, Keqin, Ukropec, Jon, Qi, Ming, Lin, Thomas S., Rifkin, Robert M.

Volltext

Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia von Raval, Aparna, Tanner, Stephan M., Byrd, John C., Angerman, Elizabeth B., Perko, James D., Chen, Shih-Shih, Hackanson, Björn, Grever, Michael R., Lucas, David M., Matkovic, Jennifer J., Lin, Thomas S., Kipps, Thomas J., Murray, Fiona, Weisenburger, Dennis, Sanger, Warren, Lynch, Jane, Watson, Patrice, Jansen, Mary, Yoshinaga, Yuko, Rosenquist, Richard, de Jong, Pieter J., Coggill, Penny, Beck, Stephan, Lynch, Henry, de la Chapelle, Albert, Plass, Christoph

Volltext

Solubility controls on plutonium and americium release in subsurface environments exposed to acidic processing wastes von Emerson, Hilary P., Sinkov, Sergey I., Pearce, Carolyn I., Cantrell, Kirk J., Delegard, Calvin H., Snyder, Michelle M.V., Thomas, May-Lin, Reilly, Dallas D., Buck, Edgar C., Sweet, Lucas E., Casella, Amanda J., Carter, Jennifer C., Corbey, Jordan F., Schwerdt, Ian J., Clark, Richard, Heller, Forrest D., Meier, David, Zavarin, Mavrik, Kersting, Annie B., Freedman, Vicky L.

Volltext

A product-mix decision model using green manufacturing technologies under activity-based costing von Tsai, Wen-Hsien, Chen, Hui-Chiao, Leu, Jun-Der, Chang, Yao-Chung, Lin, Thomas W.

Volltext

An exploratory study of earnings management detectability, analyst coverage and the impact of IFRS adoption: Evidence from China von Cang, Yongtao, Chu, Yiyun, Lin, Thomas W.

Volltext

Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma von Jakubowiak, Andrzej J, Kumar, Shaji, Medhekar, Rohan, Pei, Huiling, Lefebvre, Patrick, Kaila, Shuchita, He, Jianming, Lafeuille, Marie-Hélène, Cortoos, Annelore, Londhe, Anil, Mavros, Panagiotis, Lin, Thomas S, Usmani, Saad Z

Volltext

Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an o... von Voorhees, Peter M, Sborov, Douglas W, Laubach, Jacob, Kaufman, Jonathan L, Reeves, Brandi, Rodriguez, Cesar, Chari, Ajai, Silbermann, Rebecca, Costa, Luciano J, Anderson, Larry D, Nathwani, Nitya, Shah, Nina, Bumma, Naresh, Efebera, Yvonne A, Holstein, Sarah A, Costello, Caitlin, Jakubowiak, Andrzej, Wildes, Tanya M, Orlowski, Robert Z, Shain, Kenneth H, Cowan, Andrew J, Dinner, Shira, Pei, Huiling, Cortoos, Annelore, Patel, Sharmila, Lin, Thomas S, Usmani, Saad Z, Richardson, Paul G

Volltext

Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease von Lin, Thomas S., Ruppert, Amy S., Johnson, Amy J., Fischer, Beth, Heerema, Nyla A., Andritsos, Leslie A., Blum, Kristie A., Flynn, Joseph M., Jones, Jeffrey A., Hu, Weihong, Moran, Mollie E., Mitchell, Sarah M., Smith, Lisa L., Wagner, Amy J., Raymond, Chelsey A., Schaaf, Larry J., Phelps, Mitch A., Villalona-Calero, Miguel A., Grever, Michael R., Byrd, John C.

Volltext

Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study von Nooka, Ajay K, Kaufman, Jonathan L, Rodriguez, Cesar, Jakubowiak, Andrzej, Efebera, Yvonne, Reeves, Brandi, Wildes, Tanya M, Holstein, Sarah A, Anderson, Jr, Larry D, Badros, Ashraf, Shune, Leyla, Chari, Ajai, Pei, Huiling, Cortoos, Annelore, Patel, Sharmila, Lin, Thomas S, Voorhees, Peter M, Usmani, Saad Z, Richardson, Paul G

Volltext

Gaussian graphical modeling of the serum exposome and metabolome reveals interactions between environmental chemicals and endogenous metabolites von Bessonneau, Vincent, Gerona, Roy R., Trowbridge, Jessica, Grashow, Rachel, Lin, Thomas, Buren, Heather, Morello-Frosch, Rachel, Rudel, Ruthann A.

Volltext

Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study von Sborov, Douglas W., Baljevic, Muhamed, Reeves, Brandi, Laubach, Jacob, Efebera, Yvonne A., Rodriguez, Cesar, Costa, Luciano J., Chari, Ajai, Silbermann, Rebecca, Holstein, Sarah A., Anderson, Larry D., Kaufman, Jonathan L., Shah, Nina, Pei, Huiling, Patel, Sharmila, Cortoos, Annelore, Bartlett, J. Blake, Vermeulen, Jessica, Lin, Thomas S., Voorhees, Peter M., Richardson, Paul G.

Volltext

Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study von Czuczman, Myron S., Fayad, Luis, Delwail, Vincent, Cartron, Guillaume, Jacobsen, Eric, Kuliczkowski, Kazimierz, Link, Brian K., Pinter-Brown, Lauren, Radford, John, Hellmann, Andrzej, Gallop-Evans, Eve, DiRienzo, Christine G., Goldstein, Nancy, Gupta, Ira, Jewell, Roxanne C., Lin, Thomas S., Lisby, Steen, Schultz, Martin, Russell, Charlotte A., Hagenbeek, Anton

Volltext

Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma von Chari, Ajai, Lonial, Sagar, Mark, Tomer M., Krishnan, Amrita Y., Stockerl‐Goldstein, Keith E., Usmani, Saad Z., Londhe, Anil, Etheredge, Delores, Fleming, Sarah, Liu, Baolian, Ukropec, Jon, Lin, Thomas S., Jagannath, Sundar, Nooka, Ajay K.

Volltext

Analytical determination of radioactive strontium and cesium by Thermal Ionization Mass Spectrometry von Dion, M.P., Springer, Kellen W.E., Sumner, Ryan I., Thomas, May-Lin P., Eiden, Gregory C.

Volltext

The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo von Lucas, David M., Edwards, Ryan B., Lozanski, Gerard, West, Derek A., Shin, Jungook D., Vargo, Melissa A., Davis, Melanie E., Rozewski, Darlene M., Johnson, Amy J., Su, Bao-Ning, Goettl, Virginia M., Heerema, Nyla A., Lin, Thomas S., Lehman, Amy, Zhang, Xiaoli, Jarjoura, David, Newman, David J., Byrd, John C., Kinghorn, A. Douglas, Grever, Michael R.

Volltext

Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition von Ni, Wenjun, Ji, Jia, Dai, Zunyan, Papp, Audrey, Johnson, Amy J, Ahn, Sunjoo, Farley, Katherine L, Lin, Thomas S, Dalton, James T, Li, Xiaobai, Jarjoura, David, Byrd, John C, Sadee, Wolfgang, Grever, Michael R, Phelps, Mitch A

Volltext

Quantifying low-energy ICP-MS isotope deposition von Liezers, Martin, Dion, Michael P, Eiden, Gregory C, Thomas, May-Lin P

Volltext

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk von Callander, Natalie S., Silbermann, Rebecca, Kaufman, Jonathan L., Godby, Kelly N., Laubach, Jacob, Schmidt, Timothy M., Sborov, Douglas W., Medvedova, Eva, Reeves, Brandi, Dhakal, Binod, Rodriguez, Cesar, Chhabra, Saurabh, Chari, Ajai, Bal, Susan, Anderson, Larry D., Dholaria, Bhagirathbhai R., Nathwani, Nitya, Hari, Parameswaran, Shah, Nina, Bumma, Naresh, Holstein, Sarah A., Costello, Caitlin, Jakubowiak, Andrzej, Wildes, Tanya M., Orlowski, Robert Z., Shain, Kenneth H., Cowan, Andrew J., Pei, Huiling, Cortoos, Annelore, Patel, Sharmila, Lin, Thomas S., Giri, Smith, Costa, Luciano J., Usmani, Saad Z., Richardson, Paul G., Voorhees, Peter M.

Volltext

Phase 1 Study of Lumiliximab with Detailed Pharmacokinetic and Pharmacodynamic Measurements in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia von BYRD, John C, O'BRIEN, Susan, MOLINA, Arturo, LEIGH, Bryan, HARRIS, Sarah, FLINN, Lan W, KIPPS, Thomas J, WEISS, Mark, KANTI RAI, LIN, Thomas S, WOODWORTH, James, WYNNE, Dee, REID, Jennifer

Volltext